Harvard Apparatus Regenerative Technology Inc. has announced that it has entered into Securities Purchase Agreements with certain investors for a private placement of 411,765 shares of common stock, raising approximately $0.7 million at a purchase price of $1.70 per share. The shares were sold in an unregistered offering, relying on exemptions under Section 4(a)(2) and Rule 506 of the Securities Act, as well as similar state law exemptions, limiting the sale to accredited investors. The agreements include customary representations, warranties, and covenants between the company and the investors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-000452), on January 06, 2026, and is solely responsible for the information contained therein.